Abstract: Examples are disclosed that relate to generating expressive avatars using multi-modal three-dimensional face modeling and tracking. One example includes a computer system comprising a processor coupled to a storage system that stores instructions. Upon execution by the processor, the instructions cause the processor to receive initialization data describing an initial state of a facial model. The instructions further cause the processor to receive a plurality of multi-modal data signals. The instructions further cause the processor to perform a fitting process using the initialization data and the plurality of multi-modal data signals. The instructions further cause the processor to determine a set of parameters based on the fitting process, wherein the determined set of parameters describes an updated state of the facial model.

Abstract: A composite panel includes a backing substrate and a first plurality of fiber tows. The first plurality of fiber tows is stitched to a first surface of the backing substrate in a predetermined pattern to form a fiber reinforced insert. A first polymer layer encapsulates the first surface of the backing substrate and the first plurality of fiber tows.

Abstract: Presented are anti-buckling cables for battery assembly shear plates, methods for making/using such anti-buckling cables, and electric-drive vehicles equipped with traction battery packs having impact-attenuating shear plates joined by anti-buckling cables. A battery assembly includes multiple battery cells, such as lithium-class prismatic, pouch, or can-type cells arranged in rows and columns, that are housed inside a protective battery container, such as an electrically insulated battery pack housing. A pair of rigid, impact-attenuating (top and bottom) shear plates is attached to opposing (top and bottom) sides of the battery container, sandwiching therebetween the battery cells. An engineered pattern of tether cables extends through the battery container with cable each rigidly secured at opposing ends thereof to the two shear plates. The tether cables are electrically non-conductive and structurally join together the vertically spaced, mutually parallel shear plates.

Abstract: A composite panel includes a backing substrate and a first plurality of fiber tows. The first plurality of fiber tows is stitched to a first surface of the backing substrate in a predetermined pattern to form a fiber reinforced insert. A first polymer layer encapsulates the first surface of the backing substrate and the first plurality of fiber tows.

Abstract: A composite component includes a substrate including a first region and a second region. A plurality of first fiber tows is arranged in the first region and including non-conductive filaments. First stitches attach the plurality of first fiber tows to a first surface of the substrate. A plurality of second fiber tows are arranged in the second region and including conductive filaments. Second stitches attach the plurality of second fiber tows to the first surface of the substrate.

Abstract: A containment system for a rechargeable energy storage device (RESS) is described includes an enclosure having a first compartment adjoining a second compartment. The first compartment is arranged to house a plurality of power electronics devices, and the second compartment is arranged to house a plurality of battery cells. The second compartment includes a tub that defines a bottom portion, and a floor plate. The tub includes opposed end walls and opposed sidewalls. A top plate is arranged overtop of the first compartment and the second compartment. A first one of the end walls and the top plate define a first slot between the first compartment and the second compartment. A first removable panel is arranged to enclose the first compartment. The plurality of battery cells connect to the plurality of power electronics devices via a high-voltage DC power bus that is arranged to pass through the first slot.

Abstract: This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.

Abstract: A hybrid material housing for a battery is provided for reducing or minimizing thermal runaway propagation. The housing includes a composite structure that contains the battery and optionally includes a polymeric matrix selected from the group consisting of: epoxy, phenolic resin, polyester, vinyl ester, and combinations thereof and a reinforcing material selected from the group consisting of: glass fibers, carbon fibers, basalt fibers, aromatic polyamide KEVLAR® fibers, and combinations thereof. A metal layer is disposed along an exterior surface of the composite structure that comprises aluminum, steel, stainless steel, alloys, and combinations thereof. In a first mode, the metal layer contacts the composite structure and in a second mode after exposure to a thermal load of greater than or equal to about 500° C., the metal layer at least partially delaminates from the exterior surface and forms insulating air gaps to define a thermal barrier.

Abstract: A battery tray is provided and includes a first component and a second component. The first component includes a first set of walls, where the first set of walls includes a first stitched fabric, and where the first stitched fabric includes first metal coated fibers. The second component includes a second set of walls, where: the second set of walls includes a second stitched fabric; the second stitched fabric includes second metal coated fibers; and the second component is attached to the first component to form the battery tray, which is configured to hold a battery pack of a vehicle. The first metal coated fibers and the second metal coated fibers provide an electromagnetic shield surrounding the battery pack.

Abstract: This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.

Abstract: A method is provided for forming a near-net thermoplastic composite component includes co-spraying a mixture comprising a thermoplastic polymer material and a chopped reinforcing material deposited onto at least one region associated with a tool having a first temperature and defining a near-net component shape. The mixture and adjacent tool is heated to a second temperature while the mixture is on the tool. The first temperature is below the solidification temperature of the thermoplastic polymer material and the second temperature is above the solidification temperature. Then, the mixture is exposed to a negative pressure to promote removal of gases from the mixture and put under compressive force to densify the mixture. The thermoplastic polymer material melts and flows. The tool is cooled to the first temperature and removing the mixture to form the near-net thermoplastic composite component having randomly oriented chopped reinforcement material distributed within a thermoplastic polymer matrix.

Abstract: This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.

Abstract: This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.

Abstract: This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.

Abstract: A rocker assembly for a vehicle body structure includes a rocker rail having a boxed cross-section defining a rocker rail interior space, a rocker rail length, and a rocker rail outer surface along the length. The rocker rail defines at least one aperture connecting the interior space and the panel outer surface. The rocker assembly also includes an insert member configured to fit within the rocker rail interior space and extend along the panel length to reinforce the panel. The insert member includes at least one projection configured to match up with and extend at least partially through a respective at least one aperture. The projection(s) are configured to reinforce the rocker rail by opposing deformation of the boxed cross-section. The projection(s) oppose deformation via interference with the boxed cross-section at the respective aperture(s) when the rocker rail is subjected to an applied load perpendicular to the panel outer surface.

Abstract: A rocker assembly for a vehicle body structure includes a rocker rail having a boxed cross-section defining a rocker rail interior space, a rocker rail length, and a rocker rail outer surface along the length. The rocker rail defines at least one aperture connecting the interior space and the panel outer surface. The rocker assembly also includes an insert member configured to fit within the rocker rail interior space and extend along the panel length to reinforce the panel. The insert member includes at least one projection configured to match up with and extend at least partially through a respective at least one aperture. The projection(s) are configured to reinforce the rocker rail by opposing deformation of the boxed cross-section. The projection(s) oppose deformation via interference with the boxed cross-section at the respective aperture(s) when the rocker rail is subjected to an applied load perpendicular to the panel outer surface.

Abstract: This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.

Abstract: This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.

Abstract: The present disclosure relates to composite battery covers including one or more integral vent members configured to release pressure. An example composite battery cover includes a continuous sheet having a first stiffness and one or more vent members defined in the continuous sheet. Each of the one or more vent members may include a first area having a second stiffness and/or a second area having a third stiffness. The second stiffness may be different from the first stiffness. The third stiffness may be different from the second stiffness and/or the first stiffness. The stiffness and strength of the continuous sheet and/or one or more vent members may be controlled by variable thicknesses and/or fiber loadings.

Abstract: This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.